NEXIUM Gastro-resistant granules Ref.[6797] Active ingredients: Esomeprazole

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: AstraZeneca UK Limited, Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU, United Kingdom

Product name and form

Nexium 10 mg gastro-resistant granules for oral suspension, sachet.

Pharmaceutical Form

Gastro-resistant granules for oral suspension, sachet.

Pale yellow fine granules. Brownish granules may be visible.

Qualitative and quantitative composition

Each sachet contains: 10 mg esomeprazole (as magnesium trihydrate).

Excipients with known effect: Each sachet contains 6.8 mg sucrose and 2.8 g glucose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Esomeprazole

Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion.

List of Excipients

Esomeprazole granules:

Glycerol monostearate 40-55
Hydroxypropyl cellulose
Hypromellose
Magnesium stearate
Methacrylic acid–ethyl acrylate copolymer (1:1) dispersion 30%
Polysorbate 80
Sugar spheres (sucrose and maize starch)
Talc
Triethyl citrate

Excipient granules:

Citric acid anhydrous (for pH adjustment)
Crospovidone
Glucose
Hydroxypropyl cellulose
Yellow iron oxide (E172)
Xanthan gum

Pack sizes and marketing

Carton containing 28 or 30 sachets. Not all pack sizes may be marketed.

Sachets (containing granules): Laminate consisting of three layers: polyethylene terephthalate (PET), aluminium, low density polyethylene (LDPE) which protects the granules against moisture.

Marketing authorization holder

AstraZeneca UK Limited, Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU, United Kingdom

Marketing authorization dates and numbers

PL 17901/0253

Date of first authorisation: 28 July 2008
Date of latest renewal: 10 March 2010

Drugs

Drug Countries
NEXIUM Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.